Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

This opportunity aims to support research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. The focus is on "high priority" genetic conditions where screening may be possible in the near future, and where infants with the condition would significantly benefit from early identification and treatment. Key aspects of the job include developing accurate screening tests and demonstrating the benefits of early intervention or treatment. The scope of work involves researching and developing innovative approaches for screening and therapies. • The research should focus on conditions that can be identified through newborn screening. • The goal is to develop novel screening approaches and/or therapeutic interventions. • The focus is on "high priority" genetic conditions. • Infants with the condition should significantly benefit from early identification and treatment. • Developing accurate screening tests is a key aspect of the job. • Demonstrating the benefits of early intervention or treatment is crucial.